Antiviral treatment and statin use and risk of decompensated cirrhosis in patients with hepatitis C: a time-dependent analysis of a retrospective cohort study - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Evaluating the Impact of Antiviral Therapy and Statin Administration on the Risk of Decompensated Cirrhosis in Hepatitis C Patients: A Time-Dependent Retrospective Cohort Study

  • By

  • Kimberly A Brown

  • Stuart C Gordon

  • Yichu Wang

  • Trueman Wu

  • Sheri Trudeau

  • Loralee B Rupp

  • Yihe G Daida

  • Mark A Schmidt

  • Mei Lu

  • March 27, 2026

Share

Original Source(s)

Antiviral treatment and statin use and risk of decompensated cirrhosis in patients with hepatitis C: a time-dependent analysis of a retrospective cohort study

  • by Kimberly A Brown, Stuart C Gordon, Yichu Wang, Trueman Wu, Sheri Trudeau, Loralee B Rupp, Yihe G Daida, Mark A Schmidt, Mei Lu

  • March 27, 2026

Related Content

CCL20-CCR6 axis mediates mucosal-associated invariant T-M2 macrophage crosstalk to drive immune dysregulation in liver cirrhosis

Interplay between MASLD, obesity and type 2 diabetes: epidemiology, shared pathways and clinical implications

Case Report: Adult-onset diffuse hepatic hemangiomatosis with rapid progression: an autopsy case with diagnostic difficulty